Annual Reports

 
Quarterly Reports

 
8-K

  • 8-K (Jun 3, 2011)
  • 8-K (May 27, 2011)
  • 8-K (May 9, 2011)
  • 8-K (Apr 28, 2011)
  • 8-K (Apr 13, 2011)
  • 8-K (Mar 24, 2011)

 
Other

Drugstore.com 8-K 2007

Documents found in this filing:

  1. 8-K
  2. Ex-10.Doc
  3. Ex-99.Doc
  4. Ex-99.Doc
Prepared By R.R. Donnelley Financial -- Form 8-K
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 8-K
 
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):  01/30/2007
 
DRUGSTORE.COM, INC.
(Exact name of registrant as specified in its charter)
 
Commission File Number:  0-26137
 
DE
  
043416255
(State or other jurisdiction of
  
(IRS Employer
incorporation)
  
Identification No.)
 
411 108th Ave NE
Suite 1400
Bellevue, WA 98004
(Address of principal executive offices, including zip code)
 
(425) 372-3200
(Registrant’s telephone number, including area code)
 
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

Information to be included in the report

 
Item 2.02.    Results of Operations and Financial Condition
 
On January 31, 2007, drugstore.com, inc. issued a press release to report its financial results for the fourth quarter and fiscal year ended December 31, 2006 and certain other information. A copy of the press release is attached hereto as Exhibit 99.1.
 
 
Item 5.02.    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
 
On January 30, 2007, drugstore.com, inc. (the "Company") entered into an agreement with Robert A. Barton (the "Transition and Separation Agreement") regarding Mr. Barton's plans to resign as Vice President, Finance & Operations, Chief Financial Officer and Treasurer of the Company ("CFO"). A copy of the Transition and Separation Agreement is filed with this report as Exhibit 10.1 and is incorporated herein by reference. The summary of the Transition and Separation Agreement set forth below is qualified in its entirety by reference to the text of the Transition and Separation Agreement.

Under the Transition and Separation Agreement and subject to certain terms and conditions set forth therein, the Company and Mr. Barton have agreed to, among other things, the following:

- Mr. Barton will continue to serve as the Company's CFO until the earliest of April 30, 2007, the date on which a successor CFO commences his or her employment with the Company, or such other date as may be mutually agreed upon in writing by Mr. Barton and the Company (the "Transition Date").

- Mr. Barton will also remain available to assist the new CFO in transitioning into the role after the Transition date and until the earliest of September 30, 2007, the date on which Mr. Barton begins providing substantial, compensated services to a third party, or such other date as may be mutually agreed upon in writing by Mr. Barton and the Company (the "Separation Date").

- The Company will pay Mr. Barton his regular salary, and Mr. Barton will continue to be eligible for the benefits and perquisites that he currently enjoys through the Separation Date. The Company will also pay Mr. Barton his annual bonus for 2006.

- Mr. Barton will not be eligible for any new incentive bonus opportunities. However, subject to Mr. Barton's compliance with the terms of the Transition and Separation Agreement and any other contract with the Company by which he is bound, and at the CEO's discretion, Mr. Barton may be paid a prorated portion of his annual bonus for 2007 in early 2008.

- Stock options already granted to Mr. Barton will continue to vest up to the Separation Date. Mr. Barton will have until December 31, 2007 to exercise any vested stock options. After January 30, 2007, Mr. Barton will not be eligible for any new equity grants.

- Mr. Barton will execute a Severance and Release Agreement on or near the Separation Date that will include a general release of claims against the Company.

 
 
Item 9.01.    Financial Statements and Exhibits
 
(d)        Exhibits
10.1        Transition and Separation Agreement dated January 30, 2007
99.1        Press release dated January 31, 2007.
 

 

Signature(s)
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
 
DRUGSTORE.COM, INC.
 
 
Date: January 29, 2007
     
By:
 
/s/    Dawn G. Lepore

               
Dawn G. Lepore
               
President, Chief Executive Officer and Chairman of the Board
 
 


 

Exhibit Index
 
Exhibit No.

  
Description

EX-10.doc
  
Barton letter
EX-99.doc
  
Earnings Release
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki